OCS

13.18

0.73% 0.095

Dopo l'orario di chiusura: 13.25 0.07 +0.53%

Oculis Holding Ag (OCS)

Panoramica Notizia Cronologia dei prezzi Forum Previsione

Precedente Chiudi:

$13.09

Aprire:

$13.1

Volume 24 ore:

150.35K

Relative Volume:

0.24

Capitalizzazione di mercato:

$731.86M

Reddito:

Utile/perdita netta:

$-117.99M

Rapporto P/E:

-6.1597

EPS:

-2.1397

Flusso di cassa netto:

$-79.92M

1 W Prestazione:

+0.30%

1M Prestazione:

+18.42%

6M Prestazione:

-55.52%

1 anno Prestazione:

-26.16%

Intervallo 1D:

$12.87

$13.25

Intervallo di 1 settimana:

$12.87

$13.70

Portata 52W:

$10.52

$34.48

Oculis Holding Ag Stock (OCS) Company Profile

Nome

Oculis Holding Ag

Settore

Healthcare (1033)

Industria

Biotechnology (582)

Telefono

Indirizzo

Dipendente

Cinguettio

Prossima data di guadagno

2026-08-20

Ultimi documenti SEC

OCS's Discussions on Twitter

Compare OCS vs VRTX, REGN, ARGX, MRNA, RVMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
OCS Oculis Holding Ag	13.18	729.64M	0	-117.99M	-79.92M	-2.1397
VRTX Vertex Pharmaceuticals Inc	547.59	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	828.50	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,011.11	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	138.89	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	211.58	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Oculis Holding Ag Stock (OCS) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-12-19	Iniziato	JP Morgan	Overweight
2025-08-27	Iniziato	Needham	Buy
2023-12-05	Iniziato	Chardan Capital Markets	Buy
2023-10-05	Iniziato	Stifel	Buy
2023-06-14	Iniziato	BofA Securities	Buy
2023-06-12	Iniziato	H.C. Wainwright	Buy
2023-06-08	Iniziato	Robert W. Baird	Outperform
2023-05-10	Iniziato	Pareto	Buy
2023-04-28	Iniziato	Wedbush	Outperform

Mostra tutto

Oculis Holding Ag Borsa (OCS) Ultime notizie

Aug 20, 2026

Enterprise value to revenue forward of Oculis Holding AG – FWB:CR5 - TradingView

Aug 20, 2026

Aug 18, 2026

Oculis (OCS) Daily Review: Rises 0.38% to $13.19 at the Close; Chart Reference: $12.53 and $13.85 Define the Nearby Reference Levels for the Current SessionAnchored VWAP - vinanet.vn

Aug 18, 2026

Oculis (OCSAW) Session-Level Review: Ends Up by 6.00% at $5.04 in the Latest Session; Current Setup: the Near-Term Reference Band Stretches From $4.79 to $5.29 in the Current UpdateAggressive Growth Picks - vinanet.vn

Aug 18, 2026

Aug 16, 2026

Oculis Holding (OCS) Advances 0.94% as Shares Hold Above Key SupportDouble Top - vinanet.vn

Aug 16, 2026

Aug 14, 2026

Stifel reiterates Buy rating on Oculis stock, $40 target By Investing.com - Investing.com Nigeria

Aug 14, 2026

The Technical Signals Behind (OCS) That Institutions Follow - Stock Traders Daily

Aug 14, 2026

Four Oculis directors' restricted stock units vest in Aug. 13 notifications - Stock Titan

Aug 14, 2026

Oculis (NASDAQ:OCS) Price Target Cut to $20.00 by Analysts at JPMorgan Chase & Co. - MarketBeat

Aug 14, 2026

Does Oculis Holding AG (OCS) Have the Potential to Rally 187.83% as Wall Street Analysts Expect? - Zacks Investment Research

Aug 14, 2026

Stifel reiterates Buy rating on Oculis stock, $40 target - Investing.com

Aug 14, 2026

Aug 12, 2026

Oculis Holding AG Warrants (OCSAW) Hold Steady at $4.50 as Consolidation Range NarrowsVolatility Breakout Picks - Vinanet

Aug 12, 2026

Oculis buys out privosegtor’s global rights from Accure - Glance by Eyes On Eyecare

Aug 12, 2026

HC Wainwright Has Negative Estimate for Oculis Q3 Earnings - MarketBeat

Aug 12, 2026

Aug 11, 2026

Oculis rebuilds pipeline with Privosegtor buy from Accure - AllSci

Aug 11, 2026